NCT06618235View on ClinicalTrials.gov

Trial of THEO-260 in Ovarian Cancer Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 24, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Ovarian Cancer
Interventions
BIOLOGICAL

THEO-260

Oncolytic Virus

Trial Locations (3)

Unknown

RECRUITING

The Beatson West of Scotland Cancer Centre, Glasgow

RECRUITING

Imperial College Healthcare NHS Trust, Hammersmith Hospital, London

RECRUITING

Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford

All Listed Sponsors
lead

Theolytics Limited

INDUSTRY